STOCK TITAN

Aehr (NASDAQ: AEHR) director net-sells 10,500 shares after option exercise

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Aehr Test Systems director Fariba Danesh exercised stock options and sold shares. On April 13, 2026, she exercised a non-qualified option to acquire 7,000 shares of common stock at $2.25 per share, then sold 7,000 shares at an average price of $71.4901. On April 10, 2026, she also sold 3,500 shares at $70.045 per share in open-market transactions. After these trades, she directly held 13,143 shares of common stock, and this amount includes shares subject to unvested restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Director executes option exercise-and-sell, retaining a meaningful equity stake.

Fariba Danesh, a director of Aehr Test Systems, exercised a non-qualified option for 7,000 shares at $2.25 on April 13, 2026, then sold those 7,000 shares at about $71.49 each. She also sold 3,500 shares at $70.045 on April 10, 2026 in open-market transactions.

These transactions combine an option exercise with a net sale of 10,500 shares, a pattern often used to monetize option value. Following the trades, Danesh holds 13,143 shares directly, and the reported balance includes unvested restricted stock units, indicating she maintains ongoing equity exposure linked to company performance.

The filing shows no remaining derivative positions in the derivative summary, suggesting this option grant has been fully exercised. The overall picture is a partial reduction of equity exposure while keeping a sizable stake, consistent with routine portfolio and compensation management rather than a full exit.

Insider DANESH FARIBA
Role Director
Sold 10,500 shs ($746K)
Type Security Shares Price Value
Exercise Non-Qualified Option (right to buy) 7,000 $0.00 --
Exercise Common Stock 7,000 $2.25 $16K
Sale Common Stock 7,000 $71.4901 $500K
Sale Common Stock 3,500 $70.045 $245K
Holdings After Transaction: Non-Qualified Option (right to buy) — 8,000 shares (Direct); Common Stock — 20,143 shares (Direct)
Footnotes (1)
  1. [object Object]
Options exercised 7,000 shares at $2.25 Non-qualified option exercise on April 13, 2026
Shares sold 13 Apr 7,000 shares at $71.4901 Open-market sale on April 13, 2026
Shares sold 10 Apr 3,500 shares at $70.045 Open-market sale on April 10, 2026
Net shares sold 10,500 shares Net-sell direction from transaction summary
Shares held after 13,143 shares Direct ownership following reported transactions
Option expiration May 10, 2028 Expiration date of exercised non-qualified option
Non-Qualified Option financial
"security_title: "Non-Qualified Option (right to buy)""
restricted stock units financial
"The amount reported includes shares subject to unvested restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DANESH FARIBA

(Last)(First)(Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
Director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/10/2026S3,500D$70.04513,143(1)D
Common Stock04/13/2026M7,000A$2.2520,143D
Common Stock04/13/2026S7,000D$71.490113,143(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Option (right to buy)$2.2504/13/2026M7,00006/10/202105/10/2028Common Stock7,000$08,000D
Explanation of Responses:
1. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AEHR director Fariba Danesh do in this Form 4 filing?

Fariba Danesh exercised options and sold shares of Aehr Test Systems. She exercised a non-qualified option for 7,000 shares at $2.25 each, then sold 10,500 shares in open-market transactions at prices around $70–71.49 per share.

How many AEHR shares did Fariba Danesh sell and at what prices?

She sold a total of 10,500 AEHR common shares. On April 13, 2026, she sold 7,000 shares at an average price of about $71.4901. On April 10, 2026, she sold 3,500 shares at an average price of about $70.045 per share.

What option did Fariba Danesh exercise in the AEHR Form 4?

Danesh exercised a non-qualified stock option for 7,000 shares of Aehr common stock. The option had an exercise price of $2.25 per share and was originally exercisable beginning June 10, 2021, with an expiration date of May 10, 2028.

How many AEHR shares does Fariba Danesh hold after these transactions?

After the reported trades, Danesh directly holds 13,143 shares of Aehr common stock. A footnote explains that this reported amount includes shares subject to unvested restricted stock units, which continue to align her compensation with the company’s stock performance.

Were Fariba Danesh’s AEHR transactions open-market sales or something else?

The filing classifies the 10,500-share disposals as open-market sales. Both the 7,000-share and 3,500-share transactions use the “S” code, described as sales in open-market or private transactions, following an option exercise recorded with the “M” code.

Does Fariba Danesh still have stock options in AEHR after this Form 4?

The derivative summary section in the filing is empty, and one option for 7,000 shares was fully exercised. This indicates that, based on this filing alone, there are no remaining derivative positions for this particular reported option grant.